UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.

Clinical trial NCT05148377 · COMPLETED

Trial details

NCT number: NCT05148377
Sponsor: Eurofarma Laboratorios S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemodialysis Complication

Start date: 2007-08-01
Primary completion: 2008-12-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.